Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

Week in Review: FDA approves next-generation device | More recalls for Impella heart pumps | CMS targets cardiologists

News You Need to Know Today
Week in Review: FDA approves next-generation device | More recalls for Impella heart pumps | CMS targets cardiologists
Saturday, March 7, 2026
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

This Week’s News

FDA approves next-generation CardioMEMS reader for heart failure monitoring

The updated reader is 60% smaller and offers built-in WiFi connectivity. It works with an implantable sensor to monitor a patient's PA pressure. 

READ MORE >
Abbott has secured U.S. Food and Drug Administration (FDA) approval for its CardioMEMS HERO device, a next-generation pulmonary artery (PA) pressure reader for heart failure patients.
Share on Twitter Share on Facebook Share on Linkedin

FDA approves next-generation CardioMEMS reader for heart failure monitoring

Share on Twitter Share on Facebook Share on Linkedin
Abbott has secured U.S. Food and Drug Administration (FDA) approval for its CardioMEMS HERO device, a next-generation pulmonary artery (PA) pressure reader for heart failure patients.
The updated reader is 60% smaller and offers built-in WiFi connectivity. It works with an implantable sensor to monitor a patient's PA pressure. 
READ MORE >

FDA confirms more recalls for Johnson & Johnson heart pumps due to malfunction risk

The issue, first announced to the public in February, has been linked to 22 serious injuries. Customers are urged to review the updated instructions for use to avoid any potential complications. 

READ MORE >
FDA recall medical device recall product recall
Share on Twitter Share on Facebook Share on Linkedin

FDA confirms more recalls for Johnson & Johnson heart pumps due to malfunction risk

Share on Twitter Share on Facebook Share on Linkedin
FDA recall medical device recall product recall
The issue, first announced to the public in February, has been linked to 22 serious injuries. Customers are urged to review the updated instructions for use to avoid any potential complications. 
READ MORE >

Did you make the list? CMS targets cardiologists for new heart failure payment model

More than 2,000 cardiologists are required to participate in the new payment model. According to CMS, the long-term goal is to track and reduce the high healthcare costs associated with treating heart failure.

READ MORE >
Growing physician shortages have spurred rising salaries as health systems and practices attempt to attract or retain staff. The survey data from over 37,000 physician shows the average physician pay in the U.S. increased 3.7% from 2023 to 2024, but is lower than the prior year. Cardiologist salary and compensation data.
Share on Twitter Share on Facebook Share on Linkedin

Did you make the list? CMS targets cardiologists for new heart failure payment model

Share on Twitter Share on Facebook Share on Linkedin
Growing physician shortages have spurred rising salaries as health systems and practices attempt to attract or retain staff. The survey data from over 37,000 physician shows the average physician pay in the U.S. increased 3.7% from 2023 to 2024, but is lower than the prior year. Cardiologist salary and compensation data.
More than 2,000 cardiologists are required to participate in the new payment model. According to CMS, the long-term goal is to track and reduce the high healthcare costs associated with treating heart failure.
READ MORE >

Cardiologist surrenders medical license after faking penile cancer diagnosis

An interventional cardiologist has lost his ability to practice in multiple states after faking a cancer diagnosis, lying about his training and allegedly asking a colleague to falsify documents. 

READ MORE >
artificial intelligence AI in healthcare
Share on Twitter Share on Facebook Share on Linkedin

Cardiologist surrenders medical license after faking penile cancer diagnosis

Share on Twitter Share on Facebook Share on Linkedin
artificial intelligence AI in healthcare
An interventional cardiologist has lost his ability to practice in multiple states after faking a cancer diagnosis, lying about his training and allegedly asking a colleague to falsify documents. 
READ MORE >

Cardiologists perform first TAVR of its kind by anchoring valve to crushed stent

The patient, 78, presented with severe AR and no signs of calcification. She was considered a poor choice for surgery or traditional TAVR due to multiple risks. That is where the new-look ATLAS technique came in.

READ MORE >
After traversing the aortic cusp with an electrified wire and balloon inflation, a stent is positioned inside the noncoronary cusp and deployed. Immediately after, a transcatheter aortic valve is expanded, and the stent is crushed on the left ventricular outflow tract wall and annulus, while anchored to the aortic valve leaflet.
Share on Twitter Share on Facebook Share on Linkedin

Cardiologists perform first TAVR of its kind by anchoring valve to crushed stent

Share on Twitter Share on Facebook Share on Linkedin
After traversing the aortic cusp with an electrified wire and balloon inflation, a stent is positioned inside the noncoronary cusp and deployed. Immediately after, a transcatheter aortic valve is expanded, and the stent is crushed on the left ventricular outflow tract wall and annulus, while anchored to the aortic valve leaflet.
The patient, 78, presented with severe AR and no signs of calcification. She was considered a poor choice for surgery or traditional TAVR due to multiple risks. That is where the new-look ATLAS technique came in.
READ MORE >

How recreational Adderall use affects the heart: a cardiologist’s warning

Students sometimes take unprescribed Adderall to stay up late and study. According to new research out of Mayo Clinic, however, that may do more to the heart than those students realize. 

READ MORE >
heart health attack cardiology
Share on Twitter Share on Facebook Share on Linkedin

How recreational Adderall use affects the heart: a cardiologist’s warning

Share on Twitter Share on Facebook Share on Linkedin
heart health attack cardiology
Students sometimes take unprescribed Adderall to stay up late and study. According to new research out of Mayo Clinic, however, that may do more to the heart than those students realize. 
READ MORE >

New heart device for ‘no-option’ chest pain patients shows early potential

The self-expanding, recapturable coronary sinus reducer was associated with a safe implant procedure and "promising" outcomes after six months. Additional research is already underway.

READ MORE >
Image of the A-FLUX Reducer System for chest pain by VahatiCor.
Share on Twitter Share on Facebook Share on Linkedin

New heart device for ‘no-option’ chest pain patients shows early potential

Share on Twitter Share on Facebook Share on Linkedin
Image of the A-FLUX Reducer System for chest pain by VahatiCor.
The self-expanding, recapturable coronary sinus reducer was associated with a safe implant procedure and "promising" outcomes after six months. Additional research is already underway.
READ MORE >

Johnson & Johnson launches 3 new stroke devices

These devices were developed to help clinicians reach and remove distal clots associated with significant pain and swelling. If left untreated, such clots can lead to medical emergencies and even death.

READ MORE >
Cereglide 57 image courtesy of Johnson & Johnson MedTech.
Share on Twitter Share on Facebook Share on Linkedin

Johnson & Johnson launches 3 new stroke devices

Share on Twitter Share on Facebook Share on Linkedin
Cereglide 57 image courtesy of Johnson & Johnson MedTech.
These devices were developed to help clinicians reach and remove distal clots associated with significant pain and swelling. If left untreated, such clots can lead to medical emergencies and even death.
READ MORE >

GLP-1 drugs and healthy habits work together to boost heart health, Harvard study confirms

When patients on GLP-1 therapy also make healthy lifestyle choices—getting enough sleep and exercising, for example—the benefits are significantly greater. 

READ MORE >
Semaglutide (Wegovy) injector pen. Photo by Dave Fornell
Share on Twitter Share on Facebook Share on Linkedin

GLP-1 drugs and healthy habits work together to boost heart health, Harvard study confirms

Share on Twitter Share on Facebook Share on Linkedin
Semaglutide (Wegovy) injector pen. Photo by Dave Fornell
When patients on GLP-1 therapy also make healthy lifestyle choices—getting enough sleep and exercising, for example—the benefits are significantly greater. 
READ MORE >

New AI-enabled heart failure implant shows early potential

The AI-powered Relief System is able to modulate venous pressure using hemodynamic data. The goal is to help patients better manage heart failure congestion at home. 

READ MORE >
The Relief System from Relief Cardiovascular Inc. is a first of its kind device. It incorporates a valve and sensor implant that uses AI to intelligently modulate venous pressure using hemodynamic data. The system actively adjusts flow in the inferior vena cava (IVC), which lowers venous pressure to drive durable decongestion in heart failure.
Share on Twitter Share on Facebook Share on Linkedin

New AI-enabled heart failure implant shows early potential

Share on Twitter Share on Facebook Share on Linkedin
The Relief System from Relief Cardiovascular Inc. is a first of its kind device. It incorporates a valve and sensor implant that uses AI to intelligently modulate venous pressure using hemodynamic data. The system actively adjusts flow in the inferior vena cava (IVC), which lowers venous pressure to drive durable decongestion in heart failure.
The AI-powered Relief System is able to modulate venous pressure using hemodynamic data. The goal is to help patients better manage heart failure congestion at home. 
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

TAVR Highlights: Self-expanding valves continue to impress | A new technique | Why implant depth matters | SAPT vs. DAPT
Recall announced after 3 injuries | Medical societies respond to government report | New-look pacemaker requires no implant
Is coffee bad for the heart? | FDA approves new hypertension drug | Stolen devices sold to patients | BP drug recalled
OIG questions vascular procedures | Things to consider before signing your next contract | Is coffee bad for the heart?
Looking Back: Cardiovascular care hit by major recalls | New payment model on the way | SMART update | Trends in cardiac CT
Another Impella warning | Devices stolen, sold to patients | FDA impressed by new AI software | SAPT after TAVR
Week in Review: FDA confirms recall for vascular device | BATMAN to the rescue | Prasugrel after PCI | GLP-1 drugs & AFib

Pagination

    • Current page 1
    • Page 2
    • Page 3
    • Page 4
    • Page 5
    • Page 6
    • Page 7
    • Page 8
    • Page 9 …
    • Next page ››
    • Last page Last »
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
 
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
 
Design by Adaptive Theme
Trimed Popup